| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0002 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0002 |